StockpollyBeta
Get App
Popularity #2,832
CRBU · NASDAQ · Biotechnology

Caribou Biosciences (CRBU)

Develops genome-edited allogeneic CAR-T candidates for blood cancers.

$1.35
After hours−0.00 (−0.13%)
At close$1.35(+3.85%)

In millions of USD, except per-share figures

In millionsQ3 FY23Sep 2023Q4 FY23Dec 2023Q1 FY24Mar 2024Q2 FY24Jun 2024Q3 FY24Sep 2024Q4 FY24Dec 2024Q1 FY25Mar 2025Q2 FY25Jun 2025Q3 FY25Sep 2025Q4 FY25Dec 2025Q1 FY26Mar 2026Q2 FY26Jun 2026
Revenue2442322232421
Cost of revenue2921130302122010
Gross profit−5223−28−2811−20421
10394846101144499322827
Research & development293134353030362822242119
108151161010109988
Selling & marketing0−20−100000000
General & administrative1010151161010109988
Other expenses−290−10−26−30−211−220−10
Operating income−15−37−46−44−38−39−43−48−29−28−26−25
5356433−72111
Interest income500000000000
Other non-operating income0−3−5−6−4−1−3−12−2−1−11
Income before tax−10−34−41−38−35−35−40−54−28−27−25−24
Income tax expense000000000−100
Net income from continuing operations−10−35−41−38−35−35−40−54−28−26−25−24
Net income−10−35−41−38−35−35−40−54−28−26−25−24
EPS, basic−$0.12−$0.39−$0.46−$0.42−$0.38−$0.39−$0.43−$0.58−$0.30−$0.28−$0.26−$0.24
EPS, diluted−$0.12−$0.39−$0.46−$0.42−$0.38−$0.39−$0.43−$0.58−$0.30−$0.28−$0.26−$0.24
Weighted average shares, basic8488899090909393939596101
Weighted average shares, diluted8488899090909393939596101
EBITDA−13−34−41−37−34−37−39−34−27−26−24−26
Depreciation & amortization211111111110
EBIT−15−34−41−38−35−38−40−35−28−27−25−26